The Institute “Dr Simo Milošević” in Igalo, Montenegro, is regaining attention from Norwegian healthcare sectors as indications emerge of a potential resumption of patient inflow from Norway. This development signifies a pivotal moment for the Institute, which has recently navigated financial challenges and is now reestablishing its position within Europe’s medical tourism and rehabilitation landscape.
Historically, Norwegian patients have been a significant component of the Institute’s operations since 1976, primarily for rheumatic disease treatments under a state-supported program. This arrangement has proven both medically effective and economically viable, providing high-quality rehabilitation services at costs lower than those in Norway.
For the Institute, Norwegian patients have contributed between €2.7 million and €3 million annually, representing about 25% of total revenue. This income stream has been crucial in stabilizing operations amid fluctuating market conditions.
However, recent years have seen disruptions in this relationship due to operational instability and governance issues, leading to the loss of the Norwegian contract. Consequently, patients were redirected to alternative care destinations like Turkey, resulting in significant revenue losses and increased reliance on domestic demand.
In 2025–2026, the Institute embarked on a restructuring journey, moving away from near-bankruptcy towards stabilization with the support of an approximately €88 million state-backed plan. This initiative focuses on modernizing facilities and upgrading medical equipment to enhance competitiveness.
Financial performance has improved as the Institute has returned to profitability and better liquidity after years of deficits while maintaining service continuity and workforce stability. The restructuring also included recapitalization efforts from both government and private stakeholders, addressing debt issues and consolidating operations.
The renewed interest from Norway is particularly significant as the country operates a system for sending patients abroad for rehabilitation through periodic tenders that typically span multiple years. The next procurement round is anticipated in 2026 for services covering 2027–2030, presenting an opportunity for Igalo to re-enter this program.
Re-engagement with Norway would anchor Igalo back into a lucrative segment of the European healthcare market characterized by predictable demand and public-sector funding. Unlike traditional tourism, rehabilitation programs involve longer stays and stable revenue profiles.
This potential return aligns with Montenegro’s broader goal of shifting parts of its tourism sector towards higher-value services. Health tourism, particularly in rehabilitation and specialized medical fields, could help extend the tourist season and improve overall occupancy rates.
The Institute is well-positioned for this transition due to its combination of medical facilities and natural therapeutic resources like mineral waters and medicinal mud. This unique offering supports its established thalassotherapy model that distinguishes it within the regional market.
However, regaining international competitiveness will hinge on effective execution of the restructuring plan focused on capital investment and quality enhancement. Upgrading accommodation, renewing medical equipment, and retaining specialized staff are vital to meet international standards required in tenders.
The dynamics surrounding labor are also critical as the Institute has historically relied on a specialized workforce in physical medicine and rehabilitation. Retaining skilled personnel will be essential as competition for talent intensifies among European healthcare providers.
A wider geopolitical context exists as Norway’s healthcare outsourcing reflects a growing trend across Europe toward cross-border medical services driven by cost efficiencies and capacity limitations within domestic systems. For smaller economies like Montenegro, this presents an opportunity to position specialized facilities as nearshore healthcare providers for Western European markets.
Nonetheless, competition is fierce with destinations such as Turkey, Spain, and Central European spa regions enhancing their offerings through modern infrastructure and competitive pricing strategies. To regain access to the Norwegian market, Igalo must not only leverage its historical credibility but also demonstrate substantial improvements in service quality and efficiency.
The strategic benefits of securing a renewed contract with Norway would be considerable. It would provide long-term revenue stability, support further investments, and bolster the Institute’s reputation within European healthcare networks while signaling Montenegro’s capability to deliver high-quality services aligned with Western European standards.
The timing is crucial as Montenegro progresses towards EU accession, where sectors like healthcare are increasingly required to meet European quality benchmarks. Transforming Igalo into a competitive international rehabilitation center aligns with this objective.
This situation underscores a structural evolution in Montenegro’s economic model. While mass tourism remains prevalent, there is a gradual shift towards specialized segments such as luxury real estate and now potentially medical services—each relying on distinct demand profiles less affected by seasonal fluctuations.
Thus, renewed interest from Norway signifies not just a sector-specific development but reflects Montenegro’s repositioning within European service value chains towards integrated higher-value offerings.
The upcoming tender cycle will ultimately determine whether Igalo can effectively leverage its recovery into reintegration into the Norwegian system. Current signals suggest that it is being reconsidered as a credible partner—an outcome that seemed uncertain just a few years ago.
